SCHEMBL13239587

SCHEMBL13239587

CS(=O)(=O)Nc1nccc(-c2c[nH]c3ncccc23)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 11/20 0.64
CDK1 P06493 11/20 0.64
CCNB1 P14635 11/20 0.64
CCNB3 Q8WWL7 11/20 0.64
CYP3A4 P08684 1/20 0.63
ROCK1 Q13464 1/20 0.63
CCNT1 O60563 2/20 0.62
CCNA2 P20248 2/20 0.62
CDK2 P24941 2/20 0.62
CDK9 P50750 2/20 0.62
PDPK1 O15530 1/20 0.62
CCNA1 P78396 1/20 0.62
CDK5 Q00535 1/20 0.62
CDK5R1 Q15078 1/20 0.62
RET P07949 9/20 0.61
CDC7 O00311 2/20 0.60
MAP4K4 O95819 2/20 0.60
PIM1 P11309 2/20 0.60
PRKACA P17612 2/20 0.60
GSK3B P49841 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13239582 0.83 CCNB2 (0.71) CCNB2CDK1CCNB1CCNB3CCNT1
SCHEMBL15721579 0.82 DYRK1A (0.62) CCNB2CDK1CCNB1CCNB3CCNT1
SCHEMBL13239588 0.80 CDK1 (0.64) CCNB2CDK1CCNB1CCNB3CYP3A4
SCHEMBL8939628 0.80 CDK2 (0.69) CCNB2CDK1CCNB1CCNB3CCNT1
SCHEMBL8939656 0.79 CYP3A4 (1.00) CCNB2CDK1CCNB1CCNB3CYP3A4
SCHEMBL2544992 0.78 CCNB2 (1.00) CCNB2CDK1CCNB1CCNB3CCNT1
SCHEMBL13007924 0.78 CDK1 (1.00) CCNB2CDK1CCNB1CCNB3CDK2
Meriolin 1 SCHEMBL2241315 0.77 CDK9 (1.00) CCNB2CDK1CCNB1CCNB3ROCK1
SCHEMBL15721580 0.77 DYRK1A (0.70) CCNB2CDK1CCNB1CCNB3CCNT1
SCHEMBL3767765 0.77 RET (0.77) CCNB2CDK1CCNB1CCNB3RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173923-A1 4 (PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES MERCK PATENT GMBH (DE) 2010-07-08 US disclosed
US-20100173923-A1 4 (PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES MERCK PATENT GMBH (DE) 2010-07-08 US disclosed
WO-2007107221-A1 4-(PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES MERCK PATENT GMBH (DE) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173923-A1 4 (PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES MKI67, CDK4, CCNT1 CCNB2 24/4885CDK1 6/4885CCNB1 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.